Search For

Estimation of liver fibrosis and cirrhosis risk using non-invasive biomarkers in people living with HIV and prediabetes in Tanzania

Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes

Application and interpretation of non-invasive testing in MetALD

Semaglutide in MASH with F2-F3 fibrosis: a holistic perspective on the ESSENCE phase 3 trial

Immunometabolic drivers of renal fibrosis and potential therapeutic targets in diabetic kidney disease

Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions

Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy

Liver fibrosis and diabetic peripheral neuropathy in individuals with type 2 diabetes mellitus: an observational, cross-sectional study

Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes

Exploring the regulatory impact of insulin on type I collagen synthesis in hepatic stellate cells through α5β1 integrin

Mouse models of primary sclerosing cholangitis: we just can't get enough

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease